InMed Pharmaceuticals Inc. INM
Set alert
1.69 USD +0.06 +3.53%
As of Nov 3, 2:08 PM ET
1.51 Day range 1.77
0.615 52-week range 1.85
- YTD
- +59.20%
- 1 year
- -8.78%
- Open
- 1.53
- Prev close
- 1.63
- Mkt cap
- 9.26M
- Vol
- 165.43K
- Avg vol
- 67.87K
- EPS
- -2.84
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.51
- High
- 1.77
- Forward P/E
- -0.75
- Beta
- 0.71
- Short ratio
- 0.12
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2025
- 50-d avg
- 4.94
- 200-d avg
- 5.37
- 1y target
- 0.00
MAX chart
Events in this range
- Jul 6, 2020Split: 1 for 33
- Sep 7, 2022Split: 1 for 25
- Nov 5, 2026Split: 2 for 1
Signals (21)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bearish | Sep 1, 2024 | 2 years ago |
| SMA: Bullish | Aug 1, 2024 | 2 years ago |
| SMA: Bearish | May 1, 2021 | 5 years ago |
| SMA: Bullish | Apr 1, 2021 | 5 years ago |
| MACD: Buy Signal | Feb 1, 2021 | 5 years ago |
| SMA: Bearish | Jun 1, 2020 | 6 years ago |
| SMA: Bullish | May 1, 2020 | 6 years ago |
| SMA: Bearish | Mar 1, 2020 | 6 years ago |
| SMA: Bullish | Jan 1, 2020 | 6 years ago |
| SMA: Bearish | Feb 1, 2019 | 7 years ago |
| SMA: Bullish | Jan 1, 2019 | 7 years ago |
| SMA: Bearish | Oct 1, 2018 | 8 years ago |
| MACD: Sell Signal | Aug 1, 2018 | 8 years ago |
| SMA: Bearish | Jun 1, 2018 | 8 years ago |
| RSI: Overbought | Dec 1, 2017 | 8 years ago |
| SMA: Bullish | Sep 1, 2017 | 9 years ago |
| SMA: Bearish | Jul 1, 2017 | 9 years ago |
| SMA: Bullish | Dec 1, 2016 | 9 years ago |
| SMA: Bullish | Sep 1, 2016 | 10 years ago |
Newest 20 of 21.
Financial health
Altman Z-Score
-144.44 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 5
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.5×
FY 2017 5y median -0.3× FY 2026
P/S 0.0×
FY 2017 5y median 0.4× FY 2026
P/B 6.0×
FY 2017 5y median 0.2× FY 2026
P/FCF -0.0×
FY 2017 5y median -0.3× FY 2026
EV/EBITDA -0.5×
FY 2017 5y median 0.8× FY 2026
EV/Sales 0.0×
FY 2017 5y median -2.2× FY 2026
FCF Yield -133933.7%
FY 2017 5y median -365.0% FY 2026
Profitability
Gross Margin 22.3%
FY 2017 5y median 33.9% FY 2026
Operating Margin -0.3%
FY 2017 5y median -176.9% FY 2026
Net Margin -0.4%
FY 2017 5y median -166.9% FY 2026
ROE -1168.4%
FY 2017 5y median -61.0% FY 2026
ROIC -920.5%
FY 2017 5y median -58.5% FY 2026
ROA -414.5%
FY 2017 5y median -47.5% FY 2026
Growth (YoY)
Revenue 64167.3%
FY 2017 FY 2026
Operating Income -25.0%
FY 2017 FY 2026
EPS (diluted) 62.7%
FY 2017 FY 2026
Free Cash Flow -111185.8%
FY 2017 FY 2026
Financial Health
Current Ratio 1.4×
FY 2017 5y median 4.4× FY 2026
Quick Ratio 1.4×
FY 2017 5y median 3.8× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA 0.2×
FY 2017 5y median 1.1× FY 2026
Interest Coverage -925×
FY 2017 5y median 0.0× FY 2026
Dividends
Dividend Yield 6688.8%
FY 2017 5y median 0.0% FY 2026
Payout Ratio -3436.6%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-06-30
